Tecon Biology Co Ltd
SZSE:002100
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.71
8.94
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Tecon Biology Co Ltd
Total Liabilities & Equity
Tecon Biology Co Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Tecon Biology Co Ltd
SZSE:002100
|
Total Liabilities & Equity
¥16.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
13%
|
CAGR 10-Years
20%
|
|
|
Tongwei Co Ltd
SSE:600438
|
Total Liabilities & Equity
¥198.4B
|
CAGR 3-Years
36%
|
CAGR 5-Years
35%
|
CAGR 10-Years
41%
|
|
|
H
|
Heilongjiang Agriculture Co Ltd
SSE:600598
|
Total Liabilities & Equity
¥11.6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
|
B
|
Beijing Dabeinong Technology Group Co Ltd
SZSE:002385
|
Total Liabilities & Equity
¥28.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
|
New Hope Liuhe Co Ltd
SZSE:000876
|
Total Liabilities & Equity
¥124B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
|
|
Jiangxi Zhengbang Technology Co Ltd
SZSE:002157
|
Total Liabilities & Equity
¥18.3B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
11%
|
|
Tecon Biology Co Ltd
Glance View
Tecon Biology Co., Ltd. engages in the production and sale of animal vaccines, feed, and vegetable protein feed. The company is headquartered in Urumqi, Xinjiang and currently employs 5,669 full-time employees. The company went IPO on 2006-12-26. The firm's main businesses and products include premium incomes, slaughter processing and distribution of meat products, pig farming, production and distribution of feeds and veterinary drugs, and agricultural products processing. The firm mainly operates its businesses within domestic markets, with Xinjiang Province as its main market.
See Also
What is Tecon Biology Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
16.7B
CNY
Based on the financial report for Sep 30, 2024, Tecon Biology Co Ltd's Total Liabilities & Equity amounts to 16.7B CNY.
What is Tecon Biology Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
20%
Over the last year, the Total Liabilities & Equity growth was 0%. The average annual Total Liabilities & Equity growth rates for Tecon Biology Co Ltd have been 6% over the past three years , 13% over the past five years , and 20% over the past ten years .
You don't have any saved screeners yet
